Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL

Enrollment

201

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

September 30, 2001

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium low

Tiotropium 18 µg inhalation capsule

DRUG

Tiotropium high

Tiotropium 36 µg inhalation capsule

DRUG

Placebo MDI

Placebo metered dose inhaler (MDI)

DRUG

Placebo inhalation capsule

DRUG

Oxitropium

Oxitropium MDI (100 µg/puff)